Guanxinning tablet to improve heart blood flow after a heart attack
Part of Heart & circulation clinical trials.
This study tests whether a traditional Chinese medicine called Guanxinning Tablet can help improve blood flow in the tiny vessels of the heart after a heart attack treated with a stent. It may help your heart recover better and reduce future heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- This is your first heart attack and you arrived at the hospital within 12 hours of symptoms starting
- You had a stent placed or balloon angioplasty to open the blocked artery, with good blood flow after the procedure
- You are not currently taking nicorandil or other Chinese herbal medicines
- You can have an MRI scan of your heart and agree to take the study medication for 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug given shortly after a first heart attack to see if it can reduce heart damage when blood flow is restored. It is for patients having a specific type of heart attack (STEMI) and getting a procedure to open the blocked artery within 6 hours of symptoms starting.
This trial tests whether a low-dose clot-busting medicine placed into the heart artery after a primary stent can improve outcomes in people with a certain type of heart attack. It also involves short hospital follow-ups and a heart MRI to look at how the heart is recovering.
This trial tests a new way to treat heart attacks by using a special balloon to deliver medication to the heart's small blood vessels during a standard stenting procedure. It may help reduce damage to the heart muscle after a heart attack.
This trial tests a new device that may help support the heart during emergency treatment for a severe heart attack. It is for patients who have had symptoms for 6 to 24 hours and have a weakened heart muscle.
This trial tests a non-invasive method to improve blood flow in the arm during a heart attack. It may help reduce heart muscle damage before the standard artery-opening procedure.
This study tests different ways of restoring blood flow for people having a heart attack (STEMI) when the usual emergency procedure (primary PCI) may be delayed. It aims to see if giving a clot-busting medicine beforehand is as good as waiting for the procedure, or if another approach works better.
Hear when a new STEMI (ST Elevation MI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.